Endometrial Carcinosarcoma
5 clinical trials · Condition
◉ Watch Endometrial Carcinosarcoma
| Record | Firm | Date |
|---|---|---|
| A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma (NCT05156268) | Memorial Sloan Kettering Cancer Center | 2022-01-27 |
| A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) (NCT05001282) | Elucida Oncology | 2021-09-13 |
| Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib (NCT03651206) | ARCAGY/ GINECO GROUP | 2020-07-15 |
| Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment (NCT04106414) | Memorial Sloan Kettering Cancer Center | 2019-09-24 |
| A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer (NCT03015129) | Memorial Sloan Kettering Cancer Center | 2017-01-01 |
Track Endometrial Carcinosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.